{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0005083,73,MONDO:0005083,144,-1]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0005083","source":"MONDO:0005083|psoriasis","targets":["NCT00096980|A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies|COMPLETED|PHASE4|INTERVENTIONAL","NCT00110981|Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00111124|Enbrel® in Psoriatic Arthritis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00150930|Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00161655|Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00195507|Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00249808|A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies|COMPLETED|PHASE4|INTERVENTIONAL","NCT00287118|A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00312026|A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet|COMPLETED|PHASE4|INTERVENTIONAL","NCT00332332|Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00336973|A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent|COMPLETED|PHASE4|INTERVENTIONAL","NCT00436540|A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam|COMPLETED|PHASE4|INTERVENTIONAL","NCT00437619|A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.|COMPLETED|PHASE4|INTERVENTIONAL","NCT00462072|Centocor Microarray Study of Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT00581165|Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept|COMPLETED|PHASE4|INTERVENTIONAL","NCT00581555|Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00655564|Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00663052|Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00669123|Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00669214|A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp|COMPLETED|PHASE4|INTERVENTIONAL","NCT00686595|A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00697034|Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin|TERMINATED|PHASE4|INTERVENTIONAL","NCT00723437|Evaluation of the Efficacy of Acitretin Therapy for Nail Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00735787|Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet|COMPLETED|PHASE4|INTERVENTIONAL","NCT00748020|Narrow-Band UVB-Therapy in Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00763529|Elocon vs Fluticasone in Localized Psoriasis (P03197)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00791765|Moderate to Severe Plaque Psoriasis With Scalp Involvement|COMPLETED|PHASE4|INTERVENTIONAL","NCT00842153|Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam|COMPLETED|PHASE4|INTERVENTIONAL","NCT00932113|Mechanism of Action Study for Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00940862|Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00967538|Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments|COMPLETED|PHASE4|INTERVENTIONAL","NCT00992394|Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept|COMPLETED|PHASE4|INTERVENTIONAL","NCT01039142|Dose Ranging Study to Assess the Efficacy and Safety of Acitretin in Severe Plaque Type Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01053819|Can We Miss Pigmented Lesions in Psoriasis Patients?|COMPLETED|PHASE4|INTERVENTIONAL","NCT01059773|A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate|COMPLETED|PHASE4|INTERVENTIONAL","NCT01077882|Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01079988|Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence|COMPLETED|PHASE4|INTERVENTIONAL","NCT01088165|The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01132235|An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01137032|Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population|COMPLETED|PHASE4|INTERVENTIONAL","NCT01147874|Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice|COMPLETED|PHASE4|INTERVENTIONAL","NCT01149252|Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis|TERMINATED|PHASE4|INTERVENTIONAL","NCT01181570|Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea|COMPLETED|PHASE4|INTERVENTIONAL","NCT01187264|Dose Ranging Study to Compare the Efficacy and Safety of Methotrexate in Plaque Type Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01205880|Study to Evaluate Vectical in Combination With Clobex Spray to Treatment Plaque Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01223976|Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01228409|Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01265823|Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01356004|Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01429870|Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT01439425|Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01511315|The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment|COMPLETED|PHASE4|INTERVENTIONAL","NCT01543204|Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab|TERMINATED|PHASE4|INTERVENTIONAL","NCT01553058|Vascular Inflammation in Psoriasis Trial (The VIP Trial)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01714544|Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01722214|Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01745133|Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01761019|A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT01866592|Vascular Inflammation in Psoriasis - Extension Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT01971346|The Immunological Basis for Treatment Resistance to Anti-TNF Treatments|COMPLETED|PHASE4|INTERVENTIONAL","NCT02144857|Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02187172|Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)|COMPLETED|PHASE4|INTERVENTIONAL","NCT02313922|Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate|COMPLETED|PHASE4|INTERVENTIONAL","NCT02408159|Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy|TERMINATED|PHASE4|INTERVENTIONAL","NCT02550080|Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02592018|Immunologic Response to Secukinumab in Plaque Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT02602925|Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity|COMPLETED|PHASE4|INTERVENTIONAL","NCT02624544|Proton Pump Inhibitors Use in Patients With Psoriasis|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT02655705|Comparison Study of Psoriasis Severity Assessment Tools|COMPLETED|PHASE4|INTERVENTIONAL","NCT02733874|A Trial That Compound Clobetasol Propionate Ointment Treats Patients With Mild to Moderate Psoriasis Vulgaris.|COMPLETED|PHASE4|INTERVENTIONAL","NCT02829424|Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis|TERMINATED|PHASE4|INTERVENTIONAL","NCT02983981|Topical Psoriasis Study for Patients Receiving Biologic Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT02985736|Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray|COMPLETED|PHASE4|INTERVENTIONAL","NCT03022617|A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT03050294|Evaluating Treatment Resistant Dermatitis TaroIIR|COMPLETED|PHASE4|INTERVENTIONAL","NCT03080545|Enstilar in Combination With Biologic Agents|COMPLETED|PHASE4|INTERVENTIONAL","NCT03082729|Vascular Inflammation in Psoriasis - Apremilast|COMPLETED|PHASE4|INTERVENTIONAL","NCT03240809|An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT03403036|Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies|COMPLETED|PHASE4|INTERVENTIONAL","NCT03406117|A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests|COMPLETED|PHASE4|INTERVENTIONAL","NCT03440736|Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT03453190|Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03478280|Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03506477|Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color|COMPLETED|PHASE4|INTERVENTIONAL","NCT03587194|Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT03597620|Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT03629379|Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions|COMPLETED|PHASE4|INTERVENTIONAL","NCT03718299|A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT03774875|A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life|COMPLETED|PHASE4|INTERVENTIONAL","NCT03827876|Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis|RECRUITING|PHASE4|INTERVENTIONAL","NCT03904680|Studying the Effect of Methotrexate Alone Versus Methotrexate and Vitamin D on the Cardiovascular Risk of Psoriatic Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03987763|A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis|RECRUITING|PHASE4|INTERVENTIONAL","NCT03988439|A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis|RECRUITING|PHASE4|INTERVENTIONAL","NCT04119102|Duobrii in Combination With Biologics|RECRUITING|PHASE4|INTERVENTIONAL","NCT04271540|MIcrovascular dysfuNction In Moderate-severe Psoriasis|COMPLETED|PHASE4|INTERVENTIONAL","NCT04340076|Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT04347473|ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.|RECRUITING|PHASE4|INTERVENTIONAL","NCT04372277|Taltz in Combination With Enstilar for Psoriasis|RECRUITING|PHASE4|INTERVENTIONAL","NCT04417114|SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT04469829|Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome|UNKNOWN|PHASE4|INTERVENTIONAL"]}]}